Invesco Pharmaceuticals ETF
PJP
PJP
97 hedge funds and large institutions have $194M invested in Invesco Pharmaceuticals ETF in 2016 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 28 increasing their positions, 38 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.68% less ownership
Funds ownership: 17.53% → 16.85% (-0.68%)
5% less capital invested
Capital invested by funds: $205M → $194M (-$11M)
26% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 38
Holders
97
Holding in Top 10
2
Calls
$691K
Puts
$348K
Top Buyers
| 1 | +$7.59M | |
| 2 | +$5.41M | |
| 3 | +$5.34M | |
| 4 |
Goldman Sachs
New York
|
+$3.78M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.97M |
Top Sellers
| 1 | -$25.3M | |
| 2 | -$4.32M | |
| 3 | -$3.46M | |
| 4 |
VF
Virtu Financial
New York
|
-$3.26M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$1.94M |